Survivors of pediatric retinoblastoma have few cognitive and social problems during adulthood
the ONA take:
According to a new study published online in the journal Cancer, researchers have found that adults who survived childhood retinoblastoma have limited cognitive and social issues later in life.
For the study, researchers at St. Jude Children's Research Hospital in Memphis, Tennessee, sought to investigate the long-term health issues of survivors of the eye cancer following diagnosis and treatment. Although most children are cured of the disease, survivors have a higher risk of long-term health effects from intensive treatments.
The researchers identified 69 adult survivors of childhood retinoblastoma who were 33 years old on average and were treated for the treated an average of 31 years earlier. Participants then completed cognitive evaluations and questionnaires.
Results showed that survivors had few cognitive and social problems. In addition, researchers found that patients who received whole brain radiation treatment had a poorer performance on short-term and long-term verbal memory tasks.
They also found that survivors who were diagnosed before age 1 had a significantly better performance on short-term and long-term verbal memory tasks, verbal learning tasks, and verbal reasoning measures compared with those diagnosed after age 1. The researchers suggest that the brain is able to adapt and reorganize following early treatment.
Adults who survived childhood retinoblastoma have limited cognitive and social issues later in life.
- Acupuncture Improves Postoperative Symptoms in Women Undergoing Surgery for Breast Cancer
- Prehabilitation Program Improves Preoperative Fitness in Patients With Colorectal Cancer
- Combination of Gemcitabine and New CHK1 Inhibitor Is Effective in Soft Tissue Sarcomas
- Alcohol Consumption, Particularly White Wine, Associated With Increased Risk of Melanoma
- In HER2+ Breast Cancer, Higher TIL Levels Associated With Improved OS
- Exercise is as Effective in Treating Metastatic Prostate Cancer as Medication
- Walnut Consumption Changes Gut Microbiome, Decreases Growth of Colon Cancer in Mice
- Vaccine Enters Phase I Study for Safety and Effectiveness in Multiple Myeloma
- Timing Chemotherapy Administration to Circadian Rhythm Improves Drug Effectiveness
- New Therapy Blocks Breast Cancer Cells From Entering and Hiding in Bone Marrow to Form Latent Metastases
- No Difference Between RA Seed Localization and Wire Guided Localization
- BRD4 Inhibitor May Enhance Sensitivity to Endocrine Therapies
- Dual HER2 Blockade With an AI Effective in Advanced Breast Cancer
- Loperamide Regimen May Reduce Diarrhea in Neratinib-treated Patients
- PAM50 HER2-E Subtype Predicts pCR Following Lapatinib, Trastuzumab
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|